Circulating betatrophin levels are increased in anorexia and decreased in morbidly obese women

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 9, 2015, Pages E1188-E1196

  Barja Fernández, Silvia ^a,b,c   Folgueira, Cintia ^a,b   Seoane, Luisa M ^a,c   Casanueva, Felipe F ^c   Dieguez, Carlos ^b,c   Castelao, Cecilia ^a   Agüera, Zaida ^c,d   Baños, Rosa ^c,e   Botella, Cristina ^c,f   De La Torre, Rafael ^c,g,j   Fernández García, Jose C ^c,k   Fernández Real, Jose M ^c,l   Frühbeck, Gema ^c,m   Gpmez Ambrosi, Javier ^c,m   Jiménez Murcia, Susana ^c,d,n   Tinahones, Francisco J ^c,k   Estivill, Xavier ^h,i   Fernández Aranda, Fernando ^c,d   Nogueiras, Ruben ^b,c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f UNIVERSITAT JAUME I   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h CENTRE FOR GENOMIC REGULATION CRG   (Spain)

ⁱ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^j UNIVERSITAT POMPEU FABRA   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^l HOSPITAL JOSEP TRUETA   (Spain)

^m UNIVERSITY CLINIC OF NAVARRA   (Spain)

ⁿ UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETATROPHIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE; INSULIN; LEPTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; ANOREXIA; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HOMEOSTATIC MODEL ASSESSMENT INDEX; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; MOLECULAR PATHOLOGY; MORBID OBESITY; NUTRITIONAL STATUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ANOREXIA NERVOSA; BLOOD; INSULIN RESISTANCE; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; BLOOD GLUCOSE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MIDDLE AGED; OBESITY, MORBID; PEPTIDE HORMONES; YOUNG ADULT;

EID: 84941660377     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/JC.2015-1595     Document Type: Article

References (34)

1. Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U. Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab. 2015;26(4):193-200.
2. Fruhbeck G, Gomez-Ambrosi J. Control of body weight: a physiologic and transgenic perspective. Diabetologia. 2003;46:143-172.
3. Dunmore SJ, Brown JE. The role of adipokines in β-cell failure of type 2 diabetes. J Endocrinol. 2013;216:T37-T45.
4. Ferrannini E, Mari A. β-Cell function in type 2 diabetes. Metabolism. 2014;63:1217-1227.
5. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424:786-792.
6. Ren G, Kim JY, SmasCM.Identification of RIFL, a novel adipocyteenriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303:E334-E351.
7. Quagliarini F, Wang Y, Kozlitina J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci USA. 2012; 109:19751-19756.
8. Wang Y, Quagliarini F, Gusarova V, et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA. 2013;110: 16109-16114.
9. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell. 2013;153:747-758.
10. Dong XY, Pang XW, Yu ST, et al. Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. Int J Cancer. 2004; 112:239-248.
11. Gusarova V, Alexa CA,NaE, et al. ANGPTL8/betatrophin does not control pancreatic β cell expansion. Cell. 2014;159:691-696.
12. Jiao Y, Le Lay J,YuM,Naji A, KaestnerKH.Elevated mouse hepatic betatrophin expression does not increase humanβ-cell replication in the transplant setting. Diabetes. 2014;63:1283-1288.
13. Kaestner KH. Betatrophin-promises fading and lessons learned. Cell Metab. 2014;20:932-933.
14. Stewart AF. Betatrophin versus bitter-trophin and the elephant in the room: time for a new normal in β-cell regeneration research. Diabetes. 2014;63:1198-1199.
15. Tang T, Li L, Tang J, et al. A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol. 2010;28:749-755.
16. Zhang R, Abou-Samra AB. Emerging roles of Lipasin as a critical lipid regulator. Biochem Biophys Res Commun. 2013;432:401-405.
17. Koster A, Chao YB, Mosior M, et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology. 2005;146:4943-4950.
18. Musunuru K, Pirruccello JP, Do R, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010;363:2220-2227.
19. Fenzl A, Itariu BK, Kosi L, et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014;57:1204-1208.
20. Zhang R, Abou-Samra AB. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol. 2014;13:133.
21. Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep. 2014;4:5013.
22. Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia. 2014;57:50-53.
23. Espes D, Martinell M, Carlsson PO. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol. 2014;2014:323407.
24. Hu H, Sun W, Yu S, et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care. 2014; 37:2718-2722.
25. Chen X, Lu P, He W, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab. 2015;100:E96-E100.
26. Gomez-Ambrosi J, Pascual E, Catalan V, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab. 2014;99:E2004-E2009.
27. Misra M, Klibanski A. Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol. 2014;2:581-592.
28. Tortorella A, Brambilla F, Fabrazzo M, et al. Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review. Eur Eating Disord Rev. 2014;22:307-320.
29. Solmi M, Veronese N, Favaro A, et al. Inflammatory cytokines and anorexia nervosa: a meta-analysis of cross-sectional and longitudinal studies. Psychoneuroendocrinology. 2015;51:237-252.
30. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV for Axis I disorders (SCID-I) clinician version. Washington, DC: American Psychiatric Press; 1996.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
32. McNamee R. Regression modelling and other methods to control confounding. Occup Environ Med. 2005;62:500-506, 472.
33. Fu Z, Abou-Samra AB, Zhang R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia. 2014;57:2232-2234.
34. Ahnfelt-Ronne J, Madsen OD. Betatrophin. Islets. 2014;6:e28686.